Cited by 499Cannabis and Cannabinoid ResearchStress Responses and CortisolNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal

Rodrı́guez de Fonseca, Fernando, Carrera, M. Rocı́o A., Navarro, Miguel, Koob, George F., Weiss, Friedbert·1997·Science

DOI 10.1126/science.276.5321.2050

Open this paper in CoChat — free account

Abstract

Corticotropin-releasing factor (CRF) has been implicated in the mediation of the stress-like and negative affective consequences of withdrawal from drugs of abuse, such as alcohol, cocaine, and opiates. This study sought to determine whether brain CRF systems also have a role in cannabinoid dependence. Rats were treated daily for 2 weeks with the potent synthetic cannabinoid HU-210. Withdrawal, induced by the cannabinoid antagonist SR 141716A, was accompanied by a marked elevation in extracellular CRF concentration and a distinct pattern of Fos activation in the central nucleus of the amygdala. Maximal increases in CRF corresponded to the time when behavioral signs resulting from cannabinoid withdrawal were at a maximum. These data suggest that long-term cannabinoid administration alters CRF function in the limbic system of the brain, in a manner similar to that observed with other drugs of abuse, and also induces neuroadaptive processes that may result in future vulnerability to drug dependence.

Integrity signals

Registry

Crossref · 10.1126/science.276.5321.2050

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and β-Endorphin
Vale, W., Spiess, J., RIVIER, C. L., & Rivier, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.
Morgan, J., & Curran, T. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002225 · Cited by 2,689
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Expression of C‐fos‐like protein as a marker for neuronal activity following noxious stimulation in the rat
Bullitt, E. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902960402 · Cited by 1,059
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Research works printed but not linked: 10

Hollister L., Pharmacol. Rev. 38, 1 (1986).
Fishman M. W., Rosenbaum J. F., Jabusaka D. I., Carr D. B., Res. Commun. Subst. Abuse 9, 219 (1988) ;
Pope H. G., Yurgelun-Todd D., JAMA 275, 521 (1996). · DOI
Kaymakcalan S., Bull. Narc. 25, 39 (1973);
Devane W. A., Dysarz F. A., Johnson M. R., Melvin L. S., Howlett A., Mol. Pharmacol. 34, 605 (1988);
de Fonseca F. R., et al., J. Pharmacol. Exp. Ther. 276, 56 (1996).
Koob G. F., Bloom F. E., Fed. Proc. 44, 259 (1985);
Richter R. M., Merlo Pich E., Koob G. F., Weiss F., ibid. 187, 169 (1995).
Pfahl M., Endocr. Rev. 14, 651 (1993).
Stornetta R. L., Norton F. E., Guyenet P. G., ibid. 624, 19 (1993);

Sorted by citations

Items 301–400 of 498

Recent Research on Alcohol Tolerance and Dependence
Suwaki, H., Kalant, H., Higuchi, S., Crabbe, J. C., Ohkuma, S., Katsura, M., Yoshimura, M., Stewart, R. B., Li, T., & Weiss, F. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02395.x · Cited by 29
Self-citation
Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2
Jelsing, J., Galzin, A., Guillot, E., Pruniaux, M., Larsen, P. J., & Vrang, N. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.10.014 · Cited by 28
Converging vulnerability factors for compulsive food and drug use
Serafine, K. M., O’Dell, L. E., & Zorrilla, E. P. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108556 · Cited by 29
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal
Skelton, K. H., Gutman, D. A., Thrivikraman, K. V., Nemeroff, C. B., & Owens, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0713-3 · Cited by 28
Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats
Heinrichs, S. C., Klaassen, A., Koob, G. F., Schulteis, G., Ahmed, S. H., & Souza, E. B. D. (1998) · Psychopharmacology · doi:10.1007/s002130050563 · Cited by 28
Self-citation
Cocaine, Hormones, and Behavior
Mello, N. K., & Mendelson, J. H. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50106-2 · Cited by 28
Repeated administration of Δ9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat
Corchero, J., Manzanares, J., & Fuentes, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00195-6 · Cited by 27
Cannabis or health
Ashton, H. (2002) · Current Opinion in Psychiatry · doi:10.1097/00001504-200205000-00004 · Cited by 13
Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats: Brain reward system inhibition by orexin-A and CRF
Hata, T., Chen, J., Ebihara, K., Date, Y., Ishida, Y., & Nakahara, D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07808.x · Cited by 25
Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System
Ronan, P. J., & Summers, C. H. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00006-5 · Cited by 24
Role of Corticotropin-Releasing Factor (CRF) Receptor-1 on the Catecholaminergic Response to Morphine Withdrawal in the Nucleus Accumbens (NAc)
Almela, P., Zaragoza, J. N., García-Carmona, J. A., Mora, L., Hidalgo, J. M., Milanés, M. V., & Laorden, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047089 · Cited by 28
Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: Implications for understanding the “switch” to opiate addiction
Páez-Espinosa, V., Liu, Y., Ferrini, M. G., Anghel, A., Nie, Y., Tripathi, P. V., Porche, R., Jansen, E. J., Stuart, R. C., Nillni, E. A., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.063 · Cited by 25
Reward, Motivation, and Addiction
Koob, G. F., Everitt, B. J., & Robbins, T. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00041-x · Cited by 25
Self-citation
Heavy marijuana use but not deprivation is associated with increased stressor reactivity.
Hefner, K. R., Starr, M. J., & Curtin, J. J. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000344 · Cited by 26
Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition
Orío, L., Crespo, I., López‐Moreno, J. A., Reyes‐Cabello, C., de Fonseca, F. R., & de Heras, R. G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.007 · Cited by 24
Analysis of the Medical Use of Marijuana and its Societal Implications
Taylor, H. G. (1998) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30318-7 · Cited by 24
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25
Spontaneous Withdrawal from the Triazolobenzodiazepine Alprazolam Increases Cortical Corticotropin-Releasing Factor mRNA Expression
Skelton, K. H., Nemeroff, C. B., & Owens, M. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1737-04.2004 · Cited by 23
Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future
Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.014 · Cited by 24
Long-term behavioural and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors
Moreno, M., Escuredo, L., oz, R. M., de Fonseca, F. R., & Navarro, M. A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00015 · Cited by 22
Self-citation
Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide
Garrido, M. M., Manzanares, J., & Fuentes, J. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01318-9 · Cited by 22
MDMA attenuates THC withdrawal syndrome in mice
Touriño, C., Maldonado, R. J., & Valverde, O. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0772-5 · Cited by 22
Current and emerging methods for probing neuropeptide transmission
Qian, T., Wang, H., Xia, X., & Li, Y. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102751 · Cited by 21
Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety
Reyes, B. A. S., Kravets, J. L., Connelly, K. L., Unterwald, E. M., & Bockstaele, E. J. V. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1261-6 · Cited by 21
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze
Huang, P., Liu‐Chen, L., & Kirby, L. G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.071 · Cited by 21
Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes
Palomo, T., Beninger, R. J., Kostrzewa, R. M., & Archer, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033219 · Cited by 21
Malignant neglect: Substance abuse and America's schools
(2001) · PsycEXTRA Dataset · doi:10.1037/e541052013-001 · Cited by 21
Marijuana consumption and school failure among Spanish students
Duarte, R., Escario, J., & Molina, J. A. (2005) · Economics of Education Review · doi:10.1016/j.econedurev.2005.05.004 · Cited by 20
Role of Gonadal Steroids in the Corticotropin-Releasing Hormone and Proopiomelanocortin Gene Expression Response to Δ9-Tetrahydrocannabinol in the Hypothalamus of the Rat
Corchero, J., Manzanares, J., & Fuentes, J. A. (2001) · Neuroendocrinology · doi:10.1159/000054685 · Cited by 20
Laboratory measurement of adaptive behavior change in humans with a history of substance dependence
Lane, S. D., Cherek, D. R., Dougherty, D. M., & Moeller, F. G. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00045-3 · Cited by 20
Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line
Bundey, R. A., & Kendall, D. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00173-7 · Cited by 20
Cannabinoid Interaction with Brain Reward Systems
Gardner, E. L. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_19 · Cited by 20
Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations
Mantsch, J. R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100038 · Cited by 22
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB1 cannabinoid receptors
Bortolato, M., Frau, R., Bini, V., Luesu, W., Loriga, R., Collu, M., Gessa, G. L., Ennas, M. G., & Castelli, M. P. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.002 · Cited by 19
The neurocircuitry of addiction: Implications for treatment
Koob, G. F. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.005 · Cited by 24
Self-citation
CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men
Goodwin, R. S., Baumann, M. H., Gorelick, D. A., Schwilke, E. W., Schwope, D. M., Darwin, W. D., Kelly, D. L., Schroeder, J. R., Ortemann, C., BONNET, D., et al. (2011) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.600398 · Cited by 19
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats
Wright, F., & Rodgers, R. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2916-5 · Cited by 18
Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference
Daza‐Losada, M., Miñarro, J., Aguilar, M. A., Valverde, O., & Rodríguez‐Arias, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.011 · Cited by 18
Cannabis Addiction and the Brain: a Review
Zehra, A., Burns, J. A., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17204 · Cited by 18
Subchronic Cannabinoid Agonist (WIN 55,212-2) Treatment during Cocaine Abstinence Alters Subsequent Cocaine Seeking Behavior
González‐Cuevas, G., Aujla, H., Martin‐Fardon, R., López‐Moreno, J. A., Navarro, M. A., & Weiss, F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301365 · Cited by 19
Self-citation
The Neurobiology of Addiction
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50006-4 · Cited by 18
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study
Freedland, C. S., Whitlow, C. T., Smith, H. R., & Porrino, L. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03999-9 · Cited by 18
Chapter 16 Endocannabinoid System and Fear Conditioning
Resstel, L. B. M., Moreira, F. A., & Guimarães, F. S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81016-9 · Cited by 18
α-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice
Ziółkowska, B., Gieryk, A., Wawrzczak‐Bargieła, A., KROWKA, T., Kamińska, D., Korkosz, A., Bieńkowski, P., & Przewłocki, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.001 · Cited by 17
Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats
Moreno, M., López‐Moreno, J. A., de Fonseca, F. R. G., & Navarro, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00017 · Cited by 17
Self-citation
The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor
de Fonseca, F. R., & Schneider, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00116.x · Cited by 18
Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism
Hasbi, A., Madras, B., & George, S. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.07.003 · Cited by 13
Aqueous Extract of Semen Ziziphi Spinosae Exerts Anxiolytic Effects during Nicotine Withdrawal via Improvement of Amygdaloid CRF/CRF1R Signaling
Gu, C., Zhao, Z., Zhu, X., Wu, T., Lee, B. H., Jiao, Y., Lee, C. W., Jung, D. H., Yang, C. H., Zhao, R., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/2419183 · Cited by 15
Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice
Zhou, Y., Maiya, R., Norris, E. H., Kreek, M. J., & Strickland, S. (2010) · Stress · doi:10.3109/10253891003786415 · Cited by 15
Regulation of corticotropin-releasing factor messenger RNA by nicotine in an immortalized amygdalar cell line
Kasckow, J., Regmi, A., Sheriff, S., Mulchahey, J. J., & Geracioti, T. D. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00539-1 · Cited by 15
Acute Δ-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion
Gorriti, M. Á., FERRER, B., DELARCO, I., Bermúdez‐Silva, F. J., DEDIEGO, Y., Fernández‐Espejo, E., Navarro, M. A., & RODRIGUEZDEFONSECA, F. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.004 · Cited by 14
Self-citation
Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis
Bortolato, M., Bini, V., & Tambaro, S. (2010) · Pharmaceuticals · doi:10.3390/ph3092799 · Cited by 17
Dark Agouti and Fischer 344 rats: differential behavioral responses to morphine and biochemical differences in the ventral tegmental area
Brodkin, E. S., Kosten, T. A., Haile, C. N., Heninger, G. R., Carlezon, W. A., Jatlow, P. I., Remmers, E. F., Wilder, R. L., & Nestler, E. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00291-7 · Cited by 14
Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial
Baltes‐Flueckiger, L., Steinauer, R., Meyer, M., Vogel, M., & Walter, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1139325 · Cited by 15
The dark side of compulsive eating and food addiction
Zorrilla, E. P., & Koob, G. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816207-1.00006-8 · Cited by 14
Self-citation
Cannabis dependence among long-term users in Sydney, Australia
Swift, W., Hall, W., & Copeland, J. (1997) · Cited by 13
Cannabinoids and Their Interactions with Diazepam on Modulation of Serum Corticosterone Concentration in Male Mice
Saber-Tehrani, A. S., Naderi, N., Najarkolaei, A. H., Haghparast, A., & Motamedi, F. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0030-9 · Cited by 13
- Role of the Endocannabinoid System in the Neurobiology of Suicide
Dwivedi, Y. (2012) · CRC Press eBooks · doi:10.1201/b12215-11 · Cited by 12
Understanding and Treating Alcohol Dependence
Johnson, B. A., Koob, G. F., Schuckit, M. A., Mason, B. J., & Ait‐Daoud, N. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2005.00066.x · Cited by 12
Self-citation
Emerging targets for addiction neuropharmacology
Ubaldi, M., Cannella, N., & Ciccocioppo, R. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.018 · Cited by 11
β-lactams modulate astroglial glutamate transporters and attenuate dependence to CP 55,940, a CB1 receptor agonist, in rat model
Hakami, A. Y., Alshehri, F. S., & Sari, Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.09.015 · Cited by 11
The hypothalamic-pituitary-adrenal (HPA) axis: A major mediator of the adaptive responses to stress
Gabry, K. E., Chrousos, G. P., & Gold, P. W. (2003) · Neuroimmune biology · doi:10.1016/s1567-7443(03)80055-8 · Cited by 12
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice
Eckard, M. L., & Kinsey, S. G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108554 · Cited by 10
Neurobiological Theories of Addiction
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50046-1 · Cited by 11
Self-citation
How cannabis works in the brain
Iversen, L. L. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543630.004 · Cited by 10
Animal Models of Drug Dependence: Motivational Perspective
Koob, G. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_15 · Cited by 10
Self-citation
Nicotine
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50043-6 · Cited by 10
Self-citation
Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception
Iyer, V., Saberi, S. A., Pacheco, R., Sizemore, E. F., Stockman, S., Kulkarni, A., Cantwell, L., Thakur, G. A., & Hohmann, A. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110052 · Cited by 9
New Developments in Drug Dependence Studies. Characteristics of abnormal behavior induced by .DELTA.9-tetrahydrocannabinol in rats.
Fujiwara, M. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.117.35 · Cited by 9
Sleep deprivation engages the orexin/hypocretin system to regulate food reward seeking
Rojo, A. L. A., Barnhardt, T. R., Pham, T. Q., Heim, B., Cai, L., Tseng, G. C., & Huang, Y. H. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf047 · Cited by 10
Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice
Eckard, M. L., Trexler, K. R., Kotson, B. T., Anderson, K. G., & Kinsey, S. G. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172966 · Cited by 8
Chapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
Anxious Behavior of Adult CD1 Mice Perinatally Exposed to Low Concentrations of Ethanol Correlates With Morphological Changes in Cingulate Cortex and Amygdala
Madarnas, C., Villalba, N., Soriano, D., & Brusco, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00092 · Cited by 7
Mechanisms of Action of Anxiolytics
Bourin, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_18 · Cited by 7
Extended amygdala, conditioned withdrawal and memory consolidation
Baidoo, N., & Leri, F. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110435 · Cited by 7
Induction of Glycerol Phosphate Dehydrogenase Gene Expression During Seizure and Analgesia
Link, W., Kauselmann, G., Mellström, B., Kuhl, D., & Naranjo, J. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751419.x · Cited by 7
Drogennot- und -todesfälle
Püschel, K., & Schmoldt, A. (2003) · Springer eBooks · doi:10.1007/978-3-642-55866-5_5 · Cited by 7
Données neurobiologiques récentes sur le cannabis
Costentin, J. (2002) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)34338-9 · Cited by 7
Receptor and Nonreceptor Membrane-Mediated Effects of THC and Cannabinoids
Nahas, G. G., Harvey, D. J., Sutin, K. M., & Agurell, S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_78 · Cited by 7
Genetic Factors Involved in Central Nervous System/Immune Interactions
Wilder, R. L., Griffiths, M. M., Cannon, G. W., Caspi, R. R., Gulko, P. S., & Remmers, E. F. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_7 · Cited by 7
The Decade 1989–1998 in Spanish Psychology: An Analysis of Research in Psychobiology
Tejada, P., & Tedó, C. M. (2001) · The Spanish Journal of Psychology · doi:10.1017/s113874160000576x · Cited by 6
Pharmacology and Treatments
Iversen, L. L., Morris, K., & Nutt, D. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50009-8 · Cited by 6
Cannabinoid dependence induces sustained changes in GABA release in the globus pallidus without affecting dopamine release in the dorsal striatum: A dual microdialysis probe study
Moreno, M., Decara, J. M., Pavón, F. J., Stouffer, D. G., Edwards, S., Serrano, A., Suárez, J., Parsons, L. H., & de Fonseca, F. R. (2018) · Addiction Biology · doi:10.1111/adb.12694 · Cited by 5
Research in Addiction: An Update
Pope, H. G. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.304-a · Cited by 5
Le cannabis est-il un produit dopant ?
Mura, P., Trouvé, R., & Mauco, G. (2000) · Toxicorama · doi:10.1051/ata/2000029 · Cited by 5
Sleep disturbance after cessation of cannabis administration in mice
Asano, T., Takemoto, H., Horita, T., Tokutake, T., Izuo, N., Mochizuki, T., & Nitta, A. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12329 · Cited by 5
Participation and Consumption of Illegal Drugs among Adolescents
Duarte, R., Escario, J., & Molina, J. A. (2005) · International Advances in Economic Research · doi:10.1007/s11294-005-2277-5 · Cited by 5
Introduction The Neurobiology of Cannabinoid Transmission: From Anandamide Signaling to Higher Cerebral Functions and Disease
Navarro, M. A., & de Fonseca, F. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0216 · Cited by 5
Self-citation
The paraphilias: A dialectically informed review of etiology, development, and process
Walters, G. D. (1997) · Sexual Addiction & Compulsivity The Journal of Treatment and Prevention · doi:10.1080/10720169708404229 · Cited by 5
Object Relations Brief Therapy: The Therapeutic Relationship in Short-Term Work
Horowitz, M. J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.298 · Cited by 5
Where Are We and Where Are We Going?
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0008 · Cited by 5
Opioid System Involvement in Cannabinoid Tolerance and Dependence
Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5
La década 1989-1998 en la Psicología Española:Un análisis de la Investigación en Psicobiología
Tejada, P., & Tedó, C. M. (2002) · Papeles del Psicólogo - Psychologist Papers · Cited by 5
Role of the Endocannabinoid System in the Neurobiology of Suicide
Vinod, K. (2012) · Frontiers in neuroscience · doi:10.1201/b12215-6 · Cited by 4
‘Me, my classmates and my buddies’: analysing peer group effects on student marijuana consumption
Duarte, R., Escario, J., & Molina, J. (2009) · Education Economics · doi:10.1080/09645290902796332 · Cited by 4
Common Substrates of Dysphoria in Stimulant Drug Abuse and Primary Depression: Therapeutic Targets
Baicy, K., Bearden, C. E., Monterosso, J. R., Brody, A. L., Isaacson, A. J., & London, E. D. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(04)65005-7 · Cited by 4
Morphine treatment selectively regulates expression of rat pituitary POMC and the prohormone convertases PC1/3 and PC2
Nie, Y., Ferrini, M. G., Liu, Y., Anghel, A., Espinosa, E. V. P., Stuart, R. C., Lutfy, K., Nillni, E. A., & Friedman, T. C. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.006 · Cited by 4
Early Cannabinoid Exposure as a Source of Vulnerability to Opiate Addiction: A Model in Laboratory Rodents
Navarro, M., & de Fonseca, F. R. (1998) · The Spanish Journal of Psychology · doi:10.1017/s1138741600005394 · Cited by 4
Self-citation
How cannabis works in the brain
Iversen, L. L. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.002 · Cited by 4

Authors: Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F.
Affiliations: F. Rodrı́guez de Fonseca and M. Navarro, Instituto Complutense de Drogodependencias, Departamento de Psicobiologı́a, Facultad de Psicologı́a, Universidad Complutense de Madrid, 28223 Madrid, Spain.
Universidad Complutense de Madrid (ES)
Corresponding author: Navarro, Miguel
ORCID: Navarro, Miguel
Koob, George F.
Weiss, Friedbert
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1997-06-27
Volume: 276
Issue: 5321
Pages: 2050-2054
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.276.5321.2050
OpenAlex: W2124997151
Cited by: 499
References: 45
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 3 · 2019: 11 · 2018: 19 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 8 · 2013: 12 · 2012: 21
FWCI: 27.34
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r03da008426-02)
National Institute on Drug Abuse (DA 08426)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: corticotropin-releasing factor, cannabinoid withdrawal, HU-210, SR141716A, Fos activation, central amygdala, limbic system, neural adaptation, drug addiction, stress response
MeSH terms: Rimonabant, Amygdala, Animals, Anxiety, Behavior, Animal, Brain, Corticosterone, Corticotropin-Releasing Hormone, Male, Piperidines, Pyrazoles, Receptors, Drug, Substance Withdrawal Syndrome, Dronabinol, Proto-Oncogene Proteins c-fos, Rats, Wistar, Microdialysis, Receptors, Cannabinoid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks